Pneumococcal proteins that may constitute the next generation vaccine for pneumococcal disease

International Congress Series

Volumn 1257, Issue C, 2003, Pages 27-31

  Briles, David E ^a,b   Hollingshead, Susan K ^a   Crain, Marilyn J ^b   Ren, Bing ^a   Mirza, Shaper ^a   Watt, James ^a   Johnston, Jason ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Autolysin; Common protein vaccine; Neuraminidase; PcpA; Pneumolysin; PsaA; PspA; PspC; Streptococcus pneumoniae

Indexed keywords

EID: 85010072615     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(03)01157-9     Document Type: Article

References (29)

1. Shinefield, H.R., Black, S., Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr. Infect. Dis. J. 19:4 (2000), 394–397.
2. Shapiro, E.D., Berg, A.T., Austrian, R., et al. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:21 (1991), 1453–1460.
3. Di Fabio, J.L., Castaneda, E., Agudelo, C.I., et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999, PAHO Sireva-Vigia Study Group, Pan American Health Organization. Pediatr. Infect. Dis. J. 20:10 (2001), 959–967.
4. Paton, J.C., Briles, D.E., Streptococcus pneumoniae vaccines. Ellis, R.W., Brodeur, B.R., (eds.) New Bacterial Vaccines, 2003, Landes Bioscience, Georgetown, TX, 294–310.
5. D.E. Briles, J.C. Paton, S.K. Hollingshead, Pneumococcal common proteins and other vaccine strategies, in: M.M. Levine, J.B. Kaper, R. Rappuoli, M. Liu, M. Good (Eds.), New Generation Vaccines, Marcel Dekker, New York, NY, in press.
6. Briles, D.E., Ades, E., Paton, J.C., et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 68:2 (2000), 796–800.
7. Claverys, J.-P., Granadel, C., Berry, A.M., Paton, J.C., Penicillin tolerance in Streptococcus pneumoniae autolysis and the Psa ATP binding cassette (ABC) manganese permease. Mol. Microbiol. 32 (1999), 881–891 (letter to editor).
8. Lawrence, M.C., Pilling, P.A., Epa, V.C., Berry, A.M., Ogunniyi, A.D., Paton, J.C., The crystal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and a novel structure for a putative ABC-type binding protein. Structure 6:12 (1998), 1553–1561.
9. Dave, S., Brooks-Walter, A., Pangburn, M.K., McDaniel, L.S., PspC, a pneumococcal surface protein, binds human factor H. Infect. Immun. 69:5 (2001), 3435–3437.
10. Jarva, H., Janulczyk, R., Hellwage, J., Zipfel, P.F., Bjorck, L., Meri, S., Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded hic protein that binds to short consensus repeats 8–11 of factor H. J. Immunol. 168:4 (2002), 1886–1894.
11. Zhang, J.-R., Mostov, K.E., Lamm, M.E., et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102 (2000), 827–837.
12. Ren, B., Szalai, A.J., Thomas, O., Hollingshead, S.K., Briles, D.E., Both family 1 and family 2 PspAs can inhibit complement deposition and confer virulence to a capsular 3 serotype Streptococcus pneumoniae. Infect. Immun. 71 (2003), 75–85.
13. McCool, T.L., Cate, T.R., Moy, G., Weiser, J.N., The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195:3 (2002), 359–365.
14. Briles, D.E., Hollingshead, S.K., King, J., et al. Immunization of humans with rPspA elicits antibodies, which passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J. Infect. Dis. 182 (2000), 1694–1701.
15. Lock, R.A., Hansman, D., Paton, J.C., Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae. Microb. Pathog. 12 (1992), 137–143.
16. Brooks-Walter, A., Briles, D.E., Hollingshead, S.K., The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect. Immun. 67 (1999), 6533–6542.
17. Ogunniyi, A.D., Woodrow, M.C., Poolman, J.T., Paton, J.C., Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect. Immun. 69:10 (2001), 5997–6003.
18. Neeleman, C., Sibyl, P.M., Geelen, S.P., et al. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by binding of complement regulatory protein factor H. Infect. Immun. 67 (1999), 4517–4524.
19. Tu, A.-H.T., Fulgham, R.L., McCory, M.A., Briles, D.E., Szalai, A.J., Pneumococcal surface protein A (PspA) inhibits complement activation by Streptococcus pneumoniae. Infect. Immun. 67 (1999), 4720–4724.
20. Paton, J.C., Rowan-Kelly, B., Ferrante, A., Activation of human complement by the pneumococcal toxin pneumolysin. Infect. Immun. 43 (1984), 1085–1087.
21. Ogunniyi, A.D., Folland, R.L., Briles, D.B., Hollingshead, S.K., Paton, J.C., Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect. Immun. 68:5 (2000), 3028–3033.
22. Balachandran, P., Brooks-Walter, A., Virolainen-Julkunen, A., Hollingshead, S.K., Briles, D.E., The role of pneumococcal surface protein C (PspC) in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70 (2002), 2526–2534.
23. Berry, A.M., Paton, J.C., Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect. Immun. 68 (2000), 133–140.
24. Briles, D.E., Hollingshead, S.K., Paton, J.C., et al. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J. Infect. Dis. 188:3 (2003), 339–348.
25. Wu, H.-Y., Nahm, M., Guo, Y., Russell, M., Briles, D.E., Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage and infection with Streptococcus pneumoniae. J. Infect. Dis. 175 (1997), 839–846.
26. Paton, J.C., Lock, R.A., Lee, C.-J., et al. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect. Immun. 59 (1991), 2297–2304.
27. Briles, D.E., Paton, J.C., Nahm, M.H., Swiatlo, E., Immunity to Streptococcus pneumoniae. Cunningham, M., Fujinami, R.S., (eds.) Effect of Microbes on the Immune System, 2000, Lippincott-Raven, Philadelphia, 263–280.
28. Briles, D.E., Forman, C., Horowitz, J.C., et al. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect. Immun. 57 (1989), 1457–1464.
29. Binder, C.J., Horkko, S., Dewan, A., et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9:6 (2003), 736–743.